Safety of outpatient closed-loop control: First randomized crossover trials of a wearable artificial pancreas

Diabetes Care

Volumn 37, Issue 7, 2014, Pages 1789-1796

  Kovatchev, Boris P ^a   Renard, Eric ^b   Cobelli, Claudio ^c   Zisser, Howard C ^d   Keith Hynes, Patrick ^a   Anderson, Stacey M ^a   Brown, Sue A ^a   Chernavvsky, Daniel R ^a   Breton, Marc D ^a   Mize, Lloyd B ^a   Farret, Anne ^b   Place, Jérôme ^b   Bruttomesso, Daniela ^c   Del Favero, Simone ^c   Boscari, Federico ^c   Galasso, Silvia ^c   Avogaro, Angelo ^c   Magni, Lalo ^e   Di Palma, Federico ^e   Toffanin, Chiara ^e   Messori, Mirko ^e   Dassau, Eyal ^f   Doyle III, Francis J ^f   more..

^a UNIVERSITY OF VIRGINIA   (United States)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF PADOVA   (Italy)

^d SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF PAVIA   (Italy)

^f University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLOSED LOOP CONTROL; COMPUTER INTERFACE; CONFERENCE PAPER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; MOBILE APPLICATION; OPEN LOOP CONTROL; OUTPATIENT CARE; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT OUTCOME; BLOOD; CHEMICALLY INDUCED; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; INSULIN INFUSION; MIDDLE AGED; MOBILE PHONE; OUTPATIENT;

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CELL PHONES; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; OUTPATIENTS; PANCREAS, ARTIFICIAL; TREATMENT OUTCOME;

EID: 84903551043     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2076     Document Type: Article

References (27)

1. Cobelli C, Renard E, Kovatchev BP. Artificial pancreas: past, present, future. Diabetes 2011;60:2672-2682
2. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939
3. Clarke WL, Anderson SM, Breton MD, Patek SD, Kashmer L, Kovatchev BP. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Tech 2009;3:1031-1038
4. Bruttomesso D, Farret A, Costa S, et al. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Tech 2009;3:1014-1021
5. Hovorka R, Allen JM, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743-751
6. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010;2:27ra27
7. Dassau E, Zisser H, Percival MW, Grosman B, Jovanovič L, Doyle FJ III. Clinical results of automated artificial pancreatic β-cell system with unannounced meal using multi-parametric MPC and insulin-on-board. Diabetes 2010;59(Suppl. 1):A94
8. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M. MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care 2010;33:1072-1076
9. Renard EM, Farret A, Place J, Cobelli C, Kovatchev BP, Breton MD. Closed-loop insulin delivery using subcutaneous infusion and glucose sensing, and equipped with a dedicated safety supervision algorithm, improves safety of glucose control in type 1 diabetes. Diabetologia 2010;53(Suppl. 1):S25
10. Hovorka R, Kumareswaran K, Harris J, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011;342:d1855
11. Dassau E, Zisser H, Harvey R, et al. Clinical evaluation of a personalized artificial pancreas. Diabetes Care 2013;36:801-809
12. Kovatchev BP. Closed loop control for type 1 diabetes. BMJ 2011;342:d1911
13. Breton M, Farret A, Bruttomesso D, et al.; International Artificial Pancreas Study Group. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237
14. Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833
15. Nimri R, Muller I, Atlas E, et al. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis. Pediatr Diabetes 2013;15:91-99
16. Keith-Hynes P, Guerlain S, Mize B, et al. DiAs user interface: a patient-centric interface for mobile artificial pancreas systems. J Diabetes Sci Tech 2013;7:1416-1426
17. Kovatchev BP, Breton MD, Keith-Hynes PT, Patek SD. Unified platform for monitoring and control of blood glucose levels in diabetic patients. International application no. PCT/US2012/043910. 23 June 2012
18. O'Grady MJ, Retterath AJ, Keenan DB, et al. The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35:2182-2187
19. Cobelli C, Renard E, Kovatchev BP, et al. Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care 2012;35:e65-e67
20. Kovatchev BP, Renard E, Cobelli C, et al. Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36:1851-1858
21. Kovatchev BP, Cobelli C, Renard E, Zisser H. Efficacy of outpatient closed-loop control (CLC). Presented at the 73rd Scientific Sessions of the American Diabetes Association, 21-25 June 2013, Chicago, IL
22. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 1998;21:1870-1875 (Pubitemid 28478285)
23. Place J, Robert A, Ben Brahim N, et al. DiAs web monitoring: a real-time remote monitoring systemdesigned for artificial pancreas outpatient trials. J Diabetes Sci Tech 2013;7:1427-1435
24. Patek SD, Magni L, Dassau E, et al. Modular closed-loop control of diabetes. IEEE Trans Biomed Eng 2012;59:2986-2999
25. Hughes CS, Patek SD, Breton MD, Kovatchev BP. Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data. J Diabetes Sci Technol 2010;4:1146-1155
26. Ellingsen C, Dassau E, Zisser H, et al. Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board. J Diabetes Sci Technol 2009;3:536-544
27. Soru P, De Nicolao G, Toffanin C, et al.; AP@home Consortium. MPC based artificial pancreas: strategies for individualization and meal compensation. Annu Rev Contr 2012;36:118-128